EP1085859A4 - Wundbehandlung zur hemmung der adenosinetriphosphoteribosyltransferase - Google Patents

Wundbehandlung zur hemmung der adenosinetriphosphoteribosyltransferase

Info

Publication number
EP1085859A4
EP1085859A4 EP99927490A EP99927490A EP1085859A4 EP 1085859 A4 EP1085859 A4 EP 1085859A4 EP 99927490 A EP99927490 A EP 99927490A EP 99927490 A EP99927490 A EP 99927490A EP 1085859 A4 EP1085859 A4 EP 1085859A4
Authority
EP
European Patent Office
Prior art keywords
inhibition
wound treatment
adenosine diphosphate
ribosyl transferase
diphosphate ribosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99927490A
Other languages
English (en)
French (fr)
Other versions
EP1085859A1 (de
Inventor
Samuel J Leibovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of EP1085859A1 publication Critical patent/EP1085859A1/de
Publication of EP1085859A4 publication Critical patent/EP1085859A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99927490A 1998-06-11 1999-06-11 Wundbehandlung zur hemmung der adenosinetriphosphoteribosyltransferase Withdrawn EP1085859A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8892498P 1998-06-11 1998-06-11
US88924P 1998-06-11
PCT/US1999/013264 WO1999063982A1 (en) 1998-06-11 1999-06-11 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase

Publications (2)

Publication Number Publication Date
EP1085859A1 EP1085859A1 (de) 2001-03-28
EP1085859A4 true EP1085859A4 (de) 2003-02-26

Family

ID=22214311

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99927490A Withdrawn EP1085859A4 (de) 1998-06-11 1999-06-11 Wundbehandlung zur hemmung der adenosinetriphosphoteribosyltransferase

Country Status (5)

Country Link
EP (1) EP1085859A4 (de)
JP (1) JP2002517436A (de)
AU (1) AU4438399A (de)
CA (1) CA2329160A1 (de)
WO (1) WO1999063982A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064214A2 (en) * 2000-02-28 2001-09-07 The University Of British Columbia Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
US6538030B2 (en) * 2000-09-20 2003-03-25 Yih-Lin Chung Treating radiation fibrosis
DE10225772A1 (de) * 2002-06-10 2003-12-24 Beiersdorf Ag Kosmetische oder dermatologische Formulierungen zur Pflege der Haut nach einem Sonnenbad oder einer Rasur
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
AU2006235489A1 (en) 2005-04-12 2006-10-19 Intradigm Corporation Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
US7893244B2 (en) 2005-04-12 2011-02-22 Intradigm Corporation Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
EP2494965A3 (de) 2005-04-15 2013-01-02 The Albert Einstein College Of Medicine Of Yeshiva University Vitamin K zur Vorbeugung und Behandlung von zur Behandlung mit Anti-EGF-Rezeptor sekundärem Hautausschlag
FR2885802A1 (fr) * 2005-05-17 2006-11-24 Oreal Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
EP2712613B1 (de) * 2012-09-28 2017-02-08 Pharmadab d.o.o. Vitamin K1 und Verwendungen davon
TWI578994B (zh) * 2014-03-27 2017-04-21 中央研究院 燒燙傷口癒合組合物

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2074627A1 (en) * 1970-01-13 1971-10-08 Socres Ppsoriasis treatment compsn
US4289757A (en) * 1978-02-28 1981-09-15 The Upjohn Company Method for treating inflammation
EP0552439A1 (de) * 1991-12-02 1993-07-28 VALETUDO S.r.l. Topische pharmazeutische Zusammensetzungen zur Behandlung von Psoriasis und von verlagerter Hautentzündung
EP0638309A1 (de) * 1993-07-14 1995-02-15 ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. Proteische-ADP-Ribosidierung hemmende Stoffe geeignet zum Vorbeugen der Diabetes-Mellitus-Komplikationen
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases
WO1997039733A1 (en) * 1996-04-23 1997-10-30 The Procter & Gamble Company Methods of regulating skin appearance with vitamin b3 compound
WO1997039746A1 (en) * 1996-04-22 1997-10-30 Advanced Polymer Systems, Inc. Method of and composition for treating disorders of the skin using vitamin k

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029770A (en) * 1974-03-26 1977-06-14 Caw Industries, Inc. Method of therapeutically treating damaged and/or infected tissue and relieving stress and shock in warm blooded animals

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2074627A1 (en) * 1970-01-13 1971-10-08 Socres Ppsoriasis treatment compsn
US4289757A (en) * 1978-02-28 1981-09-15 The Upjohn Company Method for treating inflammation
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
EP0552439A1 (de) * 1991-12-02 1993-07-28 VALETUDO S.r.l. Topische pharmazeutische Zusammensetzungen zur Behandlung von Psoriasis und von verlagerter Hautentzündung
EP0638309A1 (de) * 1993-07-14 1995-02-15 ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. Proteische-ADP-Ribosidierung hemmende Stoffe geeignet zum Vorbeugen der Diabetes-Mellitus-Komplikationen
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases
WO1997039746A1 (en) * 1996-04-22 1997-10-30 Advanced Polymer Systems, Inc. Method of and composition for treating disorders of the skin using vitamin k
WO1997039733A1 (en) * 1996-04-23 1997-10-30 The Procter & Gamble Company Methods of regulating skin appearance with vitamin b3 compound

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALLPORT JENNIFER R ET AL: "A possible role for mono(ADP-ribosyl) transferase in the signalling pathway mediating neutrophil chemotaxis.", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. 42, no. 1, 1996, pages 99 - 106, XP009001943, ISSN: 0306-5251 *
GORIO A ET AL: "Endogenous mono-ADP-ribosylation in retina and peripheral nervous system. Effects of diabetes.", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. UNITED STATES 1997, vol. 419, 1997, pages 289 - 295, XP009001944, ISSN: 0065-2598 *
MCLIGEYO S O ET AL: "DIABETIC ULCERS A CLINICAL AND BACTERIOLOGICAL STUDY", EAST AFRICAN MEDICAL JOURNAL, vol. 68, no. 3, 1991, pages 204 - 209, XP001120779, ISSN: 0012-835X *
See also references of WO9963982A1 *
UYEDA K ET AL: "KAPOSI SARCOMA-LIKE GRANULOMA ON DIAPER DERMATITIS A REPORT OF 5 CASES", ARCHIVES OF DERMATOLOGY, vol. 107, no. 4, 1973, pages 605 - 607, XP009001941, ISSN: 0003-987X *
WALLIS R A ET AL: "TRAUMATIC NEUROPROTECTION WITH INHIBITORS OF NITRIC OXIDE AND ADP-RIBOSYLATION", BRAIN RESEARCH, AMSTERDAM, NL, vol. 710, 1996, pages 169 - 177, XP002924679, ISSN: 0006-8993 *
WEIGERT ROBERTO ET AL: "Characterization of chemical inhibitors of brefeldin A-activated mono-ADP-ribosylation.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 22, 1997, pages 14200 - 14207, XP002224494, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
EP1085859A1 (de) 2001-03-28
CA2329160A1 (en) 1999-12-16
WO1999063982A1 (en) 1999-12-16
AU4438399A (en) 1999-12-30
JP2002517436A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
EP1087770A4 (de) Inhibitoren der prenyl-protein transferase
EP0833633A4 (de) Inhibitoren der farnesyl-protein-transferase
EP0862435A4 (de) Inhibitoren der farnesyl-protein-transferase
EP0841919A4 (de) Inhibitoren der farnesyl-protein transferase
EP0817629A4 (de) Farnesylprotein transferase inhibitoren
EP0891350A4 (de) Inhibioten der farnesylprotein-transferase
EP1011669A4 (de) Farnesyl-protein transferase inhibitoren
GB9604311D0 (en) Inhibitors of farnesyl-protein transferase
EP1045844A4 (de) Inhibitoren von farnesyl-protein-transferase
EP1091736A4 (de) Inhibitoren der prenyl-protein transferase
GB9809869D0 (en) Inhibition of protein kinases
EP0891360A4 (de) Inhibitoren der farnesyl-protein transferase
EP0904080A4 (de) Inhibitoren der farnesyl-protein transferase
EP0880320A4 (de) Inhibitoren der farnesyl-protein transferase
EP1085859A4 (de) Wundbehandlung zur hemmung der adenosinetriphosphoteribosyltransferase
EP0891349A4 (de) Inhibitoren von farnesylprotein-transferase
EP0817630A4 (de) Inhibitoren der farnesyl-protein transferase
EP0891352A4 (de) Inhibitoren der farnesyl-protein transferase
EP1035852A4 (de) Hemmer von farnesyl-protein transferase
EP1035850A4 (de) Inhibitoren der farnesyl-protein transferase
EP0891335A4 (de) Inhibitoren von farnesylprotein-transferase
EP0891353A4 (de) Farnesyl-protein transferase inhibitoren
EP1035849A4 (de) Farnesyl-protein transferase inhibitoren
EP0959883A4 (de) Inhibitoren der farnesyl-protein-transferase
EP1023270A4 (de) Inhibitoren der farnesyl-protein-transferase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/37 B

Ipc: 7A 61K 31/70 B

Ipc: 7A 61K 31/35 B

Ipc: 7A 61K 31/455 B

Ipc: 7A 61K 31/12 B

Ipc: 7A 61K 31/045 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030113

17Q First examination report despatched

Effective date: 20030429

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031111